FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy.

[1]  A. El-Osta,et al.  Chromatin modifications remodel cardiac gene expression. , 2014, Cardiovascular research.

[2]  Zhiping Weng,et al.  ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers , 2014, Bioinform..

[3]  Noa Dagan,et al.  Erbin is a negative modulator of cardiac hypertrophy , 2014, Proceedings of the National Academy of Sciences.

[4]  T. Thum,et al.  Non-coding RNAs in cardiac remodeling and heart failure. , 2013, Circulation research.

[5]  Y. Hiroi,et al.  FHL2 prevents cardiac hypertrophy in mice with cardiac‐specific deletion of ROCK2 , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  B. Hendrich,et al.  Transcriptional repressors: multifaceted regulators of gene expression , 2013, Development.

[7]  Bengt Phung,et al.  Restricted leucine zipper dimerization and specificity of DNA recognition of the melanocyte master regulator MITF. , 2012, Genes & development.

[8]  H. Zhang,et al.  c-Myb Regulates Cell Cycle-Dependent Expression of Erbin: An Implication for a Novel Function of Erbin , 2012, PloS one.

[9]  B. Rothermel,et al.  FHL2 Binds Calcineurin and Represses Pathological Cardiac Growth , 2012, Molecular and Cellular Biology.

[10]  David C. Lee,et al.  A transcriptional network underlies susceptibility to kidney disease progression , 2012, EMBO molecular medicine.

[11]  D. Geerts,et al.  FHL2 Protein Is a Novel Co-repressor of Nuclear Receptor Nur77* , 2011, The Journal of Biological Chemistry.

[12]  Kristen Jepsen,et al.  Deconstructing repression: evolving models of co-repressor action , 2010, Nature Reviews Genetics.

[13]  T. Down,et al.  Differential DNA Methylation Correlates with Differential Expression of Angiogenic Factors in Human Heart Failure , 2010, PloS one.

[14]  K. Aoki,et al.  The Scaffold Protein Shoc2/SUR-8 Accelerates the Interaction of Ras and Raf* , 2010, The Journal of Biological Chemistry.

[15]  H. Nechushtan,et al.  Microphthalmia Transcription Factor Isoforms in Mast Cells and the Heart , 2007, Molecular and Cellular Biology.

[16]  Michael C. Ostrowski,et al.  Eos, MITF, and PU.1 Recruit Corepressors to Osteoclast-Specific Genes in Committed Myeloid Progenitors , 2007, Molecular and Cellular Biology.

[17]  Ronen Beeri,et al.  Transcription factor MITF regulates cardiac growth and hypertrophy. , 2006, The Journal of clinical investigation.

[18]  M. Beckerle,et al.  The LIM domain: from the cytoskeleton to the nucleus , 2004, Nature Reviews Molecular Cell Biology.

[19]  J. Licht,et al.  The LIM-only Protein DRAL/FHL2 Interacts with and Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein* , 2002, The Journal of Biological Chemistry.

[20]  R. Bassel-Duby,et al.  Cardiac-Specific LIM Protein FHL2 Modifies the Hypertrophic Response to &bgr;-Adrenergic Stimulation , 2001, Circulation.

[21]  Qiang Zhou,et al.  Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system , 2000, Mechanisms of Development.

[22]  D. Birnbaum,et al.  ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor , 2000, Nature Cell Biology.

[23]  K P Fung,et al.  Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. , 1998, Gene.

[24]  H. Nechushtan,et al.  Microphthalmia (mi) in murine mast cells: regulation of its stimuli-mediated expression on the translational level. , 1997, Blood.

[25]  E. Morii,et al.  Regulation of mouse mast cell protease 6 gene expression by transcription factor encoded by the mi locus. , 1996, Blood.

[26]  K. J. Moore.  Insight into the microphthalmia gene. , 1995, Trends in genetics : TIG.

[27]  James A. Vaught,et al.  microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. , 1994, Genes & development.

[28]  Andrew P. Read,et al.  Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene , 1994, Nature Genetics.

[29]  A. Ferré-D’Amaré,et al.  Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences , 1994, Nature Genetics.

[30]  J. Lingrel,et al.  A helix-loop-helix transcription factor-like gene is located at the mi locus. , 1993, The Journal of biological chemistry.

[31]  N. Jenkins,et al.  Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein , 1993, Cell.

[32]  Y. Hasin,et al.  Effect of ouabain on the concentration of free cytosolic Ca++ and on contractility in cultured rat cardiac myocytes. , 1989, The Journal of pharmacology and experimental therapeutics.